Compare ONB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ONB | ICLR |
|---|---|---|
| Founded | 1834 | 1990 |
| Country | United States | Ireland |
| Employees | 4971 | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.3B |
| IPO Year | N/A | 2001 |
| Metric | ONB | ICLR |
|---|---|---|
| Price | $25.14 | $146.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $27.25 | ★ $178.62 |
| AVG Volume (30 Days) | ★ 2.7M | 1.1M |
| Earning Date | 04-22-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.93 | N/A |
| Revenue Next Year | $5.10 | N/A |
| P/E Ratio | $13.92 | ★ $12.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $19.39 | $66.57 |
| 52 Week High | $26.17 | $211.00 |
| Indicator | ONB | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 63.82 | 63.32 |
| Support Level | $24.04 | $99.11 |
| Resistance Level | $26.17 | $188.03 |
| Average True Range (ATR) | 0.47 | 8.29 |
| MACD | 0.11 | 1.04 |
| Stochastic Oscillator | 92.60 | 77.73 |
Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.